ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07615
0,03%
Bitcoin
64.153,51
0,24%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Dr Reddys Laboratories Ltd (RDY)

  7. Dr Reddys Laboratories Ltd (RDY) News

RDY Dr Reddys Laboratories Ltd

75,21
0,43 (0,58%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Dr Reddys Laboratories Ltd RDY NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,43 0,58% 75,21 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
74,89 74,705 75,43 75,21 74,78
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202414:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
22.3.202412:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
19.3.202412:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
04.3.202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.3.202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.2.202412:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.2.202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.2.202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.2.202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.2.202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.2.202412:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.2.202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.2.202418:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.2.202416:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.2.202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31.1.202415:44BWDr. Reddy’s Q3 & 9M FY24 Financial Results
31.1.202413:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202419:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202417:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.1.202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.1.202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.1.202419:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.1.202417:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.1.202414:58DJNIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky..
16.1.202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.1.202414:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.1.202412:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.1.202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.1.202412:00BWDr. Reddy's Announces the Acquisition of MenoLabs®, a..
02.1.202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.1.202412:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.12.202314:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.12.202313:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.12.202312:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.12.202312:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.12.202313:49BWDr. Reddy’s becomes first Indian pharma company to debut on..
12.12.202312:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.12.202312:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.12.202318:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.12.202317:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.12.202313:55DJNCoya Therapeutics Strikes Development, Commercialization..
06.12.202313:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
01.12.202313:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28.11.202314:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.11.202313:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.11.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.11.202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.11.202314:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.11.202312:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

NYSE
RDY
Dr Reddys Laboratories
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten